Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
D000328:Adult; D002986:Clinical Trials as Topic; D002991:Clofazimine / Q000009:adverse effects / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use*; D012867:Skin / Q000382:microbiology; D012880:Skin Pigmentation / Q000187:drug effects
D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin